Korean J Urol. 2007 Nov;48(11):1104-1108. Korean.
Published online Nov 30, 2007.
Copyright © 2007 The Korean Urological Association
Original Article

Prognosis of Transitional Cell Carcinoma of the Bladder in Patients 40 Years Old or Less: Comparison with Elderly Patients

Ki Hoon Kim, Sun Il Kim and Se Joong Kim
    • Department of Urology, Ajou University School of Medicine, Suwon, Korea.
Received August 01, 2007; Accepted August 29, 2007.

Abstract

Purpose

The natural history and prognosis of transitional cell carcinoma (TCC) of the bladder in young patients remain a matter of debate. This study aimed to evaluate whether TCC of the bladder in young patients is biologically different from that found in elderly patients.

Materials and Methods

The medical records of 21 patients presenting with TCC of the bladder at 40 years of age and younger (group 1) were reviewed and compared with those of 94 patients who were diagnosed with bladder TCC at 51 years of age and older (group 2).

Results

The initial stage distribution was similar with 85.7% and 79.8% of patients presenting with superficial TCC in group 1 and 2, respectively. The gross hematuria as a presenting symptom, multiplicity of tumor mass, T stage, N stage, M stage, concomitant carcinoma in situ (CIS) and grade were not significantly different between the two groups. There was no difference in the cancer-specific survival rate between the two groups. For the cases with superficial TCC, no difference was observed in the disease-free survival rate or progression-free survival rate between the two groups.

Conclusions

TCC of the bladder in patients 40 years old or less has a similar clinicopathological distribution and disease outcome to those observed in elderly patients. It is suggested that the management and follow-up of TCC of the bladder in young patients should be the same as those for elderly patients.

Keywords
Urinary bladder neoplasms; Transitional cell carcinoma; Age factors; Prognosis

Figures

Fig. 1
Kaplan-Meier cancer-specific survival curves showed that there was no difference in the survival rate between the two groups (p=0.905).

Fig. 2
Kaplan-Meier disease-free survival curves in patients with superficial bladder cancer. No difference was observed in the survival rate between the two groups (p=0.821).

Fig. 3
Kaplan-Meier progression-free survival curves in patients with superficial bladder cancer. No difference was observed in the survival rate between the two groups (p=0.595).

Tables

Table 1
Comparison of the clinical characteristics between young and elderly patients

Table 2
Comparison of the clinicopathological variables of bladder cancer between young and elderly patients

References

    1. Donat SM. Evaluation and follow-up strategies for superficial bladder cancer. Urol Clin North Am 2003;30:765–776.
    1. Kim WJ, Chung JI, Hong JH, Kim CS, Jung SI, Yoon DK. Epidemiological study for urologic cancer in Korea (1998-2002). Korean J Urol 2004;45:1081–1088.
    1. Fleshner N, Kondylis F. Demographics and epidemiology of urothelial cancer of the urinary bladder. In: Droller MJ, editor. Urothelial tumors. Hamilton: BC Decker; 2004. pp. 1-16.
    1. Iori F, De Dominicis C, Liberti M, Frioni D, Vahedi M, Leonardo C, et al. Superficial bladder tumors in patients under 40 years of age: clinical, prognostic and cytogenetic aspects. Urol Int 2001;67:224–227.
    1. Fine SW, Humphrey PA, Dehner LP, Amin MB, Epstein JI. Urothelial neoplasms in patients 20 years or younger: a clinicopathological analysis using the world health organization 2004 bladder consensus classification. J Urol 2005;174:1976–1980.
    1. Benson RC Jr, Tomera KM, Kelalis PP. Transitional cell carcinoma of the bladder in children and adolescents. J Urol 1983;130:54–55.
    1. Madgar I, Goldwasser B, Nativ O, Hanani Y, Jonas P. Long-term followup of patients less than 30 years old with transitional cell carcinoma of bladder. J Urol 1988;139:933–934.
    1. McCarthy JP, Gavrell GJ, LeBlanc GA. Transitional cell carcinoma of bladder in patients under thirty years of age. Urology 1979;13:487–489.
    1. Kim WJ, Lee SE, Kim YK. Transitional cell carcinoma of the bladder in the first three decades of life. Korean J Urol 1986;27:255–258.
    1. Chang SY, Ma CP. Transitional cell carcinoma of the urinary bladder in patients under 40 years of age. Br J Urol 1987;60:343–344.
    1. Stokes MA, Kelly DG. Transitional cell carcinoma in patients under forty years of age. Br J Urol 1987;59:536–539.
    1. Erozenci A, Ataus S, Pekyalcin A, Kural A, Talat Z, Solok V. Transitional cell carcinoma of the bladder in patients under 40 years of age. Int Urol Nephrol 1994;26:179–182.
    1. Witjes JA, Debruyne FM. Bladder carcinoma in patients less than 40 years of age. Urol Int 1989;44:81–83.
    1. Wan J, Grossman HB. Bladder carcinoma in patients age 40 years or younger. Cancer 1989;64:178–181.
    1. Fitzpatrick JM, Reda M. Bladder carcinoma in patients 40 years old or less. J Urol 1986;135:53–54.
    1. Yossepowitch O, Dalbagni G. Transitional cell carcinoma of the bladder in young adults: presentation, natural history and outcome. J Urol 2002;168:61–66.
    1. Cherrie RJ, Lindner A, deKernion JB. Transitional cell carcinoma of bladder in first four decades of life. Urology 1982;20:582–584.
    1. Kutarski PW, Padwell A. Transitional cell carcinoma of the bladder in young adults. Br J Urol 1993;72:749–755.
    1. Johnson DE, Hillis S. Carcinoma of the bladder in patients less than 40 years old. J Urol 1978;120:172–173.
    1. Kurz KR, Pitts WR, Vaughan ED Jr. The natural history of patients less than 40 years old with bladder tumors. J Urol 1987;137:395–397.
    1. Migaldi M, Rossi G, Maiorana A, Sartori G, Ferrari P, De Gaetani C, et al. Superficial papillary urothelial carcinomas in young and elderly patients: a comparative study. BJU Int 2004;94:311–316.
    1. Seon YB, Kim JH, Kwon SS, Kim YH, Park HJ, Kwon CH, et al. Two cases of transitional cell carcinoma of the bladder in patients younger than 20 years old. Korean J Urol 1998;39:283–285.
    1. American Joint Committee on Cancer. AJCC cancer staging manual. 5th ed. Philadelphia: Lippincott-Raven; 1997. pp. 241-243.
    1. Epstein JI, Amin MB, Reuter VR, Mostofi FK. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998;22:1435–1448.

Metrics
Share
Figures

1 / 3

Tables

1 / 2

PERMALINK